Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:
iVeliparib-AP6
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | iVeliparib-AP6 is a Veliparib-based PROTAC (proteolysis-targeting chimera) molecule that targets PARP1/2. It induces the degradation of PARP1 and PARP2 with DC50 values of 36 nM and 63 nM, respectively, and has IC50 values of 69 nM and 21 nM. This compound features a PARP inhibitor moiety derived from Veliparib, linked to the CRBN E3 ligase complex; Thalidomide acts as the ligand to recruit the CRBN E3 ubiquitin ligase, facilitating the degradation of PARP2. |
| Targets & IC50 | PARP1:69 nM |
| In vitro | iVeliparib-AP6 (10 min) inhibits the catalytic activity of PARP1 and PARP2 in cell-free assays, with IC50 values of 69 nM and 21 nM, respectively. |
| Molecular Weight | 807.89 |
| Formula | C40H53N7O11 |
| Cas No. | 2472645-27-3 |
| Smiles | O=C1C=2C(C(=O)N1C3C(=O)NC(=O)CC3)=CC=CC2NCCOCCOCCOCCOCCOCCOCCN4[C@](C)(CCC4)C=5NC=6C(N5)=CC=CC6C(N)=O |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 µL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 µL Tween 80 and mix well until fully clarified.
3) Add 450 µL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.